Parnell Pharmaceuticals Holdings Ltd Stock Nasdaq

Parnell Pharmaceuticals Holdings Ltd is an Australia-based company, which is engaged in offering the global veterinary pharmaceutical business marketing products in 14 countries. The Company operates sterile manufacturing facilities and offers digital technology platforms that integrate with the Company’s products to offer veterinarians and animal owners superior solutions for their animal health needs. The Company also provides a fully integrated animal health platform. The Company’s mySYNCH is a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. The Company’s products include GONAbreed, estroPLAN, and RESPIRmycin. GONAbreed is used for the treatment of cystic ovaries and used in cattle synchronization protocols. The estroPLAN is used in animals with unobserved or non-detected estrus in cattle undergoing synchronization protocols. The RESPIRmycin is used for the treatment of respiratory disease in beef and non-lactating dairy cattle.